BRIEF published on 09/18/2025 at 15:53, 1 year 1 month ago Novacyt nomme Singer Capital Markets comme co-courtier Cotation Boursière Novacyt Singer Capital Markets Co-courtier SP Angel
PRESS RELEASE published on 09/18/2025 at 15:50, 1 year 1 month ago Décision concernant les poursuites engagées par le HSE contre Lab 21 Résumé de la décision concernant les poursuites engagées par le HSE contre Lab 21, filiale de Novacyt. Lab 21 a plaidé coupable et payé une amende de £52,000 sans impact financier significatif sur le groupe Novacyt Amende Lab 21 HSE Poursuites
PRESS RELEASE published on 09/18/2025 at 15:48, 1 year 1 month ago Nomination d'un co-courtier pour l’entreprise Nomination d'un co-courtier Singer Capital Markets par Novacyt S.A. pour renforcer son équipe financière. Détails et contacts disponibles Finance D'entreprise Diagnostic Moléculaire Novacyt S.A. Singer Capital Markets Nouveau Co-courtier
BRIEF published on 07/28/2025 at 12:45, 1 year 3 months ago Novacyt Liquidity Contract Half-Yearly Review Liquidity Securities INVEST SECURITIES Sotck Exchange Novacyt
BRIEF published on 07/28/2025 at 12:45, 1 year 3 months ago Bilan Semestriel du Contrat de Liquidité de Novacyt Liquidité Bourse INVEST SECURITIES Titres Novacyt
PRESS RELEASE published on 07/28/2025 at 12:40, 1 year 3 months ago Liquidity Agreement Half Year Reporting H1 2025 Novacyt publie son bilan semestriel du contrat de liquidité confié à Invest Securities, avec 104 002 titres et 18 458,91€ en espèces échangés jusqu'au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Actions INVEST SECURITIES Novacyt
BRIEF published on 07/15/2025 at 11:48, 1 year 3 months ago Lancement du LightBench® Discover par Novacyt Diagnostic Moléculaire Séquençage ADN Novacyt Lancement Produit LightBench® Discover
BRIEF published on 07/15/2025 at 11:48, 1 year 3 months ago Novacyt launches LightBench® Discover Product Launch DNA Sequencing Novacyt Molecular Diagnosis LightBench® Discover
PRESS RELEASE published on 07/15/2025 at 11:43, 1 year 3 months ago Lancement de LightBench® Discover Novacyt annonce le lancement de LightBench® Discover, un instrument 3-en-1 de haute précision pour la recherche génomique. Solution tout-en-un pour séquençage longue lecture HiFi. Note technique disponible en ligne Novacyt LightBench Discover Séquençage Longue Lecture Partenaires Compatibles PacBio Recherche Génomique
BRIEF published on 06/20/2025 at 13:19, 1 year 4 months ago Novacyt Confirms Adoption of All Resolutions at its AGM Business Strategy Sustainable Growth General Assembly Novacyt Resolutions Approved
Published on 11/06/2026 at 00:53, 1 hour 23 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 31 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 21 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 2 hours 56 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 11 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 11 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 38 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 39 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 30 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 7 hours 55 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 7 hours 55 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
